Skip to search.
 TSX Down 0.62% TSX Ventures Down 0.53%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
384.52 Up 7.81(2.07%) 4:00PM EDT
|After Hours : 385.00 Up 0.48 (0.12%) 4:43PM EDT - Nasdaq Real Time Price
Prev Close:376.71
Open:377.95
Bid:355.01 x 200
Ask:385.00 x 100
1y Target Est:475.95
Beta:1.55676
Next Earnings Date: 5-May-16REGN Earnings announcement
Day's Range:369.07 - 385.00
52wk Range:348.96 - 605.93
Volume:730,188
Avg Vol (3m):970,169
Market Cap:40.20B
P/E (ttm):69.66
EPS (ttm):5.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNUp 2.07%40.20B
AMGNUp 0.44%119.25B

Key Statistics

Forward P/E (1 yr):23.58
P/S (ttm):9.56
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :11.53
Quarterly EPS Est (Mar-16) :2.61
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):1.58

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback